Novel Versus Conventional Sequencing of Beta-blockers, SGLT2i’s, ARNI’s and MRAs in Stable Patients with HFrEF (novcon Sequencing Study): Protocol for a 5-Year Pragmatic, Real World, Open Label, Randomised Clinical Trial (Preprint)